stable. SG&A The Company selling expense for the year ended 31 December 2019 and 2018 were THB 256.71 and 207.62 million respectively. Selling expense had risen by THB 49.09 million or 23.64% due mainly to
2017. There is a gross loss of 22.78% due to the expected loss estimation from one of the current construction projects. For all other completed projects in 2018 with 10% of gross profit margin still
amount 29.592 million baht, compared with the same period of 2018, gross profit amount 20.963 million baht, increasing gross profit amount 8.629 million baht or 41.163 percent increase due to Cost of sales
Ref. PDI/BK-BS-056/2018 8th August 2018 Re: Management Discussion and Analysis (MD&A) For the 2Q 2018 and 1H 2018 To: President The Stock Exchange of Thailand Due to depletion of Mae Sod Mine’s
associated with the Project include liquidity risk of contractor business and sales would not go ahead as planned due to community opposition in the area nearby Wat Lengnoeiyi, causing delay of the Project
changed by considering all stakeholders. In 2Q20, overall economy was largely affected by the coronavirus disease (COVID- 19) outbreak globally, including the Thai economy, due mainly to country lock down
. Lately, general patient revenue, especially foreign patient revenue, had been greatly affected by the significant drop in service utilization rates due to the pandemic situation. However, the Company has
. Meanwhile, domestic branded sales slightly increased. Net loss in Q2/2018 was Baht 15 million, a decrease due to 1) a one-time cost of financial advisory fees and legal consultant fees of Baht 22 million
buildings were newly completed and introduced to potential customers. Due to the accounting standard, the company had to amortize leasehold rights of these new warehouse/ factory buildings. However, the